Tolerance of nitrosurea-based multiagent chemotherapy regime for low-grade pediatric gliomas

Journal of Neuro-Oncology

Volumn 63, Issue 3, 2003, Pages 289-294

  Lancaster, Donna L ^a   Hoddes, J A ^b   Michalski, A ^b  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b Academic Department of Biochemistry   (United Kingdom)

Author keywords

Chemotherapy; Nitrosurea; Pediatric low grade gliomas

Indexed keywords

CARBOPLATIN; ETOPOSIDE; LOMUSTINE; NITROSOUREA; PROCARBAZINE; STEROID; TIOGUANINE; VINCRISTINE;

ARTICLE; BLOOD TOXICITY; BLOOD TRANSFUSION; BONE MARROW TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER INCIDENCE; CANCER RADIOTHERAPY; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DEATH; DIET SUPPLEMENTATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG FATALITY; DRUG TOLERABILITY; DRUG TOXICITY; DRUG WITHDRAWAL; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; GLIOMA; HEMIPARESIS; HUMAN; HYPERESTHESIA; INFECTION; LYMPHOCYTE COUNT; MALE; NEUROTOXICITY; NEUTROPENIA; NUTRITIONAL SUPPORT; PRIMARY MEDICAL CARE; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; TREATMENT OUTCOME; TREATMENT PLANNING; TUMOR GROWTH; WEIGHT REDUCTION;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CARBOPLATIN; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; DRUG ADMINISTRATION SCHEDULE; DRUG TOLERANCE; FEMALE; GLIOMA; HUMANS; INFANT; LOMUSTINE; MALE; NEOPLASM RECURRENCE, LOCAL; PROCARBAZINE; SALVAGE THERAPY; THIOGUANINE; TREATMENT OUTCOME; VINCRISTINE;

EID: 0037622802     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1024278925822     Document Type: Article

References (21)

1. Heideman RL, Packer RJ, Albright LA, Freeman CR, Rorke LB: Tumors of the central nervous system. In: Pizzo PA, Poplack DG (eds) Principles and Practice of Pediatric Oncology. Lippincott-Raven, Philadelphia, 1997, p 633
2. Rush JA, Younge BR, Campbell RJ, McCarty CS: Optic glioma. Long-term follow-up of 85 histopathologically verified cases. Ophthalmology 89: 1213-1219, 1982
3. Shaw EG, Scheithauer BW, Gilbertson DT, Nichols DA, Laws ER, Earle JD, Daumas-Duport C, O'Fallon JR, Dinapoli RP: Postoperative radiotherapy of supratentorial low-grade gliomas. Int J Radiat Oncol Biol Phys 16: 663-668, 1989
4. Taveras JM, Mont LA, Wood EH: The value of radiation therapy in management of gliomas of optic nerves and chiasm. Radiology 66: 518-528, 1956
5. Duffner PK, Cohen ME: The long-term effects of central nervous system therapy on children with brain tumors. Neurol Clin 9: 479-495, 1991
6. Jannoun L, Bloom HJ: Long-term psychological effects in children treated for intracranial tumors. Int J Radiat Oncol Biol Phys 18: 747-753, 1990
7. Mostow EN, Byrne J, Connelly RR, Mulvihill JJ: Quality of life in long-term survivors of CNS tumors of childhood and adolescence. J Clin Oncol 9: 592-599, 1991
8. Packer RJ, Savino PJ, Bilaniuk LT, Zimmerman RA, Schatz NJ, Rosenstock JG, Nelson DS, Jarrett PD, Bruce DA, Schut L: Chiasmatic gliomas of childhood. A reappraisal of natural history and effectiveness of cranial irradiation. Childs Brain 10: 393-403, 1983
9. Packer RJ, Sutton LN, Atkins TE, Radcliffe J, Bunin GR, D'Angio G, Siegel KR, Schut L: A prospective study of cognitive function in children receiving whole-brain radiotherapy and chemotherapy: 2-year results. J Neurosurg 70: 707-713, 1989
10. Spunberg JJ, Chang CH, Goldmann M, Auricchio E, Bell JJ: Quality of long-term survival following irradiation for intracranial tumors in children under the age of two. Int J Radiat Oncol Biol Phys 7: 727-736, 1981
11. Packer RJ, Sutton LN, Bilaniuk LT, Radcliffe J, Rosenstock JG, Siegel KR, Bunin GR, Savino PJ, Bruce DA, Schut L: Treatment of chiasmatic/hypothalamic gliomas of childhood with chemotherapy: An update. Ann Neurol 23: 79-85, 1988
12. Friedman HS, Krischer JP, Burger P, Oakes WJ, Hockenberger B, Weiner MD, Falletta JM, Norris D, Ragab AH, Mahoney DHJ: Treatment of children with progressive or recurrent brain tumors with carboplatin or iproplatin: A pediatric oncology group randomized phase II study. J Clin Oncol 10: 249-256, 1992
13. Packer RJ, Lange B, Ater J, Nicholson HS, Allen J, Walker R, Prados M, Jakacki R, Reaman G, Needles MN: Carboplatin and vincristine for recurrent and newly diagnosed low-grade gliomas of childhood. J Clin Oncol 11: 850-856, 1993
14. Packer RJ, Ater J, Allen J, Phillips P, Geyer R, Nicholson HS, Jakacki R, Kurczynski E, Needle M, Finlay J, Reaman G, Boyett JM: Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas. J Neurosurg 86: 747-754, 1997
15. Pons MA, Finlay JL, Walker RW, Puccetti D, Packer RJ, McElwain M: Chemotherapy with vincristione (VCR) and etoposide (VP-16) in children with low-grade astrocytoma. J Neuro-Oncol 14: 151-158, 1992
16. Prados MD, Edwards MS, Rabbitt J, Lamborn K, Davis RL, Levin VA: Treatment of pediatric low-grade gliomas with a nitrosourea-based multiagent chemotherapy regimen. J Neuro-Oncol 32: 235-241, 1997
17. Allen JC, Walker R, Luks E, Jennings M, Barfoot S, Tan C: Carboplatin and recurrent childhood brain tumors. J Clin Oncol 5: 459-463, 1987
18. Windom HH, MacGuire WP, Hamilton RG, Adkinson NFJ: Anaphylaxis to carboplatin - A new platinum chemotherapeutic agent. J Allergy Clin Immunol 90: 681-683, 1992
19. Pal PK: Clinical and electrophysiological studies in vincristine induced neuropathy. Electromogr Clin Neurophysiol 39: 323-330, 1999
20. MacDonald DR: Neurologic complications of chemotherapy. Neurol Clin 9: 955-967, 1991
21. Guruangan S, Cavazos CM, Ashley D, Herndon II JE, Bruggers CS, Moghrabi A, Scarcella DL, Watral M, Tourt-Uhlig S, Reardon D, Friedman HS: Phase II study of carboplatin in children with progressive low-grade gliomas. J Clin Oncol 20: 2951-2958, 2002